Structure-based design of novel bicyclic nonpeptide inhibitors for the Src SH2 domain

被引：27
|
作者：
Shakespeare, WC [1 ]
Bohacek, RS [1 ]
Azimioara, MD [1 ]
Macek, KJ [1 ]
Luke, GP [1 ]
Dalgarno, DC [1 ]
Hatada, MH [1 ]
Lu, XD [1 ]
Violette, SM [1 ]
Bartlett, C [1 ]
Sawyer, TK [1 ]
机构：
[1] ARIAD Pharmaceut Inc, Cambridge, MA 02139 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2000年 / 43卷 / 21期
关键词：
D O I：
10.1021/jm0003337
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：3815 / 3819
页数：5
相关论文
共 50 条
  • [41] Monocarboxylic-based phosphotyrosyl mimetics in the design of Grb2 SH2 domain inhibitors
    Burke, TR
    Luo, J
    Yao, ZJ
    Gao, Y
    Zhao, H
    Milne, GWA
    Guo, RB
    Voigt, JH
    King, CR
    Yang, DJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (03) : 347 - 352
  • [42] Structure-based design of peptidomimetic ligands of the Grb2-SH2 domain
    Schoepfer, J
    Gay, B
    Caravatti, G
    Garcia-Echeverria, C
    Fretz, H
    Rahuel, J
    Furet, P
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (20) : 2865 - 2870
  • [43] Nonpeptide inhibitors of cathepsin G: Optimization of a novel β-ketophosphonic acid lead by structure-based drug design
    Greco, Michael N.
    Hawkins, Michael J.
    Powell, Eugene T.
    Almond, Jr., Harold R.
    Corcoran, Thomas W.
    De, Garavilla, Lawrence
    Kauffman, Jack A.
    Recacha, Rosario
    Chattopadhyay, Debashish
    Andrade-Gordon, Patricia
    Maryanoff, Bruce E.
    Journal of the American Chemical Society, 2002, 124 (15): : 3810 - 3811
  • [44] Structure-Based Discovery of Novel Nonpeptide Inhibitors Targeting SARS-CoV-2 Mpro
    Yang, Jingyi
    Lin, Xiaoyuan
    Xing, Na
    Zhang, Zhao
    Zhang, Haiwei
    Wu, Haibo
    Xue, Weiwei
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2021, 61 (08) : 3917 - 3926
  • [45] Nonpeptide inhibitors of cathepsin G:: Optimization of a novel β-ketophosphonic acid lead by structure-based drug design
    Greco, MN
    Hawkins, MJ
    Powell, ET
    Almond, HR
    Corcoran, TW
    de Garavilla, L
    Kauffman, JA
    Recacha, R
    Chattopadhyay, D
    Andrade-Gordon, P
    Maryanoff, BE
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (15) : 3810 - 3811
  • [46] Structure-based design of an osteoclast-selective, nonpeptide Src homology 2 inhibitor with in vivo antiresorptive activity
    Shakespeare, W
    Yang, M
    Bohacek, R
    Cerasoli, F
    Stebbins, K
    Sundaramoorthi, R
    Azimioara, M
    Vu, C
    Pradeepan, S
    Metcalf, C
    Haraldson, C
    Merry, T
    Dalgarno, D
    Narula, S
    Hatada, M
    Lu, XD
    van Schravendijk, MR
    Adams, S
    Violette, S
    Smith, J
    Guan, W
    Bartlett, C
    Herson, J
    Iuliucci, J
    Weigele, M
    Sawyer, T
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (17) : 9373 - 9378
  • [47] Recent Progress of Src SH2 and SH3 Inhibitors as Anticancer Agents
    Lu, X. -L.
    Cao, X.
    Liu, X. -Y.
    Jiao, B. -H.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (12) : 1117 - 1124
  • [48] Progress towards the development of SH2 domain inhibitors
    Kraskouskaya, Dziyana
    Duodu, Eugenia
    Arpin, Carolynn C.
    Gunning, Patrick T.
    CHEMICAL SOCIETY REVIEWS, 2013, 42 (08) : 3337 - 3370
  • [49] PHOSPHATASE-RESISTANT SH2 DOMAIN INHIBITORS
    BURKE, TR
    SMYTH, MS
    OTAKA, A
    NOMIZU, M
    ROLLER, PP
    WOLF, G
    CASE, R
    SHOELSON, SE
    FASEB JOURNAL, 1994, 8 (07): : A1222 - A1222
  • [50] SH2 DOMAIN-STRUCTURE AND FUNCTION
    SCHAFFHAUSEN, B
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1995, 1242 (01): : 61 - 75
12345